Form 10-Q · Quarterly report
L3Harris 10-Q, filed Oct 29, 2026
- Filed
- CIK
- 0000202058
- Accession no.
- 0000202058-26-000087
Summary
L3Harris reported third-quarter 2026 revenue of $6.06 billion, up 7% from a year earlier, and net income available to common shareholders of $613 million, or $3.28 per diluted share; U.S. Government customers accounted for 75% of year-to-date revenue. The company completed the sale of its Space Technology disposal group on August 3, 2026.
Key points
- Year-to-date 2026 revenue rose 9% to $17.685 billion, with diluted EPS of $9.13 versus $6.92 a year earlier.
- The GFY 2027 President's Budget Request sought about $1.5 trillion for national defense, while the U.S. government began the fiscal year under a continuing resolution through December 11, 2026, limited to the GFY 2026 base budget of $860 billion.
- Almost all NATO allies committed to spend 5% of GDP annually on defense and security over the next decade.
- L3Harris said it is seeking tariff exemptions and evaluating alternative suppliers, and does not expect a material impact on its 2026 results.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION OVERVIEW We deliver mission-critical end-to-end technology solutions connecting the space, air, land, sea and cyber domains in the interest of national security. We support government customers in more than 100 countries, with our largest customers being various departments and agencies of the U.S. Government, their prime contractors and international allies. Our products, systems and services have defense and civil government applications, as well as commercial applications. The percentage of our revenue that was derived from sales to U.S. Government customers, including foreign military sales funded through the U.S. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.